Lung Cancer Screening Market Size, Share, Growth, and Industry Analysis, By Types (Low Dose Computed Tomography (LDCT), X-ray, ), By Applications (Hospitals, Diagnostic Centers, Others, ) , and Regional Insights and Forecast to 2035

Table of Content



1 Market Overview

1.1 Product Definition and Market Characteristics

1.2 Global Lung Cancer Screening Market Size

1.3 Market Segmentation

1.4 Regulatory Environment



2 Industry Chain Analysis

2.1 Industry Chain Analysis

2.2 Lung Cancer Screening Raw Materials Analysis

2.2.1 Key Raw Materials Introduction

2.2.2 Key Suppliers of Raw Materials

2.3 Lung Cancer Screening Business Mode and Production Process

2.3.1 Lung Cancer Screening Business Mode Analysis

2.3.2 Production Process Analysis

2.4 Lung Cancer Screening Cost Structure Analysis

2.4.1 Manufacturing Cost Structure of Lung Cancer Screening

2.4.2 Raw Material Cost of Lung Cancer Screening

2.4.3 Labor Cost of Lung Cancer Screening

2.5 Market Channel Analysis

2.6 Major Downstream Customers Analysis

2.7 Alternative Product Analysis



3 Market Dynamics

3.1 Market Drivers

3.2 Market Constraints and Challenges

3.3 Emerging Market Trends

3.4 PESTEL Analysis

3.5 Consumer Insights Analysis

3.6 Impact of Russia and Ukraine War



4 Market Competitive Landscape

4.1 Global Lung Cancer Screening Revenue and Market Share by Manufacturer (2021-2026)

4.2 Global Lung Cancer Screening Sales Volume and Market Share by Manufacturer (2021-2026)

4.3 Global Lung Cancer Screening Price by Manufacturer (2021-2026)

4.4 Lung Cancer Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

4.5 Global Key Manufacturers of Lung Cancer Screening, Manufacturing Base Distribution and Headquarters

4.6 Global Key Manufacturers of Lung Cancer Screening, Product Offered and Application

4.7 Lung Cancer Screening Market Competitive Situation and Trends

4.7.1 Lung Cancer Screening Market Concentration Rate

4.7.2 Global Top 3 and Top 6 Lung Cancer Screening Players Market Share by Revenue

4.8 Industry News

4.8.1 Key Product Launch News

4.8.2 Mergers & Acquisitions, Expansion Plans



5 Global Lung Cancer Screening Market Historical Development by Geographic Region (2021-2026)

5.1 Global Lung Cancer Screening Market Historical Sales Volume by Geographic Region (2021-2026)

5.2 Global Lung Cancer Screening Market Historical Revenue by Geographic Region (2021-2026)

5.3 North America Lung Cancer Screening Market Status by Country (2021-2026)

5.3.1 North America Lung Cancer Screening Sales Volume by Country (2021-2026)

5.3.2 North America Lung Cancer Screening Revenue by Country (2021-2026)

5.3.3 United States Lung Cancer Screening Sales Volume, Revenue and Growth (2021-2026)

5.3.4 Canada Lung Cancer Screening Sales Volume, Revenue and Growth (2021-2026)

5.4 Europe Lung Cancer Screening Market Status by Country (2021-2026)

5.4.1 Europe Lung Cancer Screening Sales Volume by Country (2021-2026)

5.4.2 Europe Lung Cancer Screening Revenue by Country (2021-2026)

5.4.3 Germany Lung Cancer Screening Sales Volume, Revenue and Growth (2021-2026)

5.4.4 France Lung Cancer Screening Sales Volume, Revenue and Growth (2021-2026)

5.4.5 United Kingdom Lung Cancer Screening Sales Volume, Revenue and Growth (2021-2026)

5.4.6 Spain Lung Cancer Screening Sales Volume, Revenue and Growth (2021-2026)

5.4.7 Russia Lung Cancer Screening Sales Volume, Revenue and Growth (2021-2026)

5.4.8 Poland Lung Cancer Screening Sales Volume, Revenue and Growth (2021-2026)

5.5 Asia Pacific Lung Cancer Screening Market Status by Country (2021-2026)

5.5.1 Asia Pacific Lung Cancer Screening Sales Volume by Country (2021-2026)

5.5.2 Asia Pacific Lung Cancer Screening Revenue by Country (2021-2026)

5.5.3 China Lung Cancer Screening Sales Volume, Revenue and Growth (2021-2026)

5.5.4 Japan Lung Cancer Screening Sales Volume, Revenue and Growth (2021-2026)

5.5.5 South Korea Lung Cancer Screening Sales Volume, Revenue and Growth (2021-2026)

5.5.6 Southeast Asia Lung Cancer Screening Sales Volume, Revenue and Growth (2021-2026)

5.5.7 India Lung Cancer Screening Sales Volume, Revenue and Growth (2021-2026)

5.5.8 Australia Lung Cancer Screening Sales Volume, Revenue and Growth (2021-2026)

5.6 Latin America Lung Cancer Screening Market Status by Country (2021-2026)

5.6.1 Latin America Lung Cancer Screening Sales Volume by Country (2021-2026)

5.6.2 Latin America Lung Cancer Screening Revenue by Country (2021-2026)

5.6.3 Mexico Lung Cancer Screening Sales Volume, Revenue and Growth (2021-2026)

5.6.4 Brazil Lung Cancer Screening Sales Volume, Revenue and Growth (2021-2026)

5.7 Middle East and Africa Lung Cancer Screening Market Status by Country (2021-2026)

5.7.1 Middle East and Africa Lung Cancer Screening Sales Volume by Country (2021-2026)

5.7.2 Middle East and Africa Lung Cancer Screening Revenue by Country (2021-2026)

5.7.3 GCC Lung Cancer Screening Sales Volume, Revenue and Growth (2021-2026)

5.7.4 South Africa Lung Cancer Screening Sales Volume, Revenue and Growth (2021-2026)



6 Global Lung Cancer Screening Market Historical Development by Product Type (2021-2026)

6.1 Lung Cancer Screening Definition by Type

6.2 Global Lung Cancer Screening Historical Sales Volume by Product Type (2021-2026)

6.3 Global Lung Cancer Screening Historical Revenue by Product Type (2021-2026)

6.4 Global Lung Cancer Screening Historical Price by Product Type (2021-2026)

6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)

6.5.1 Global Lung Cancer Screening Historical Sales Volume, Revenue and Growth Rate of Low Dose Computed Tomography (LDCT) (2021-2026)
6.5.2 Global Lung Cancer Screening Historical Sales Volume, Revenue and Growth Rate of X-ray (2021-2026)


7 Global Lung Cancer Screening Market Historical Development by End User (2021-2026)

7.1 Downstream Market Overview

7.2 Global Lung Cancer Screening Historical Sales Volume by End User (2021-2026)

7.3 Global Lung Cancer Screening Historical Revenue by End User (2021-2026)

7.4 Global Lung Cancer Screening Historical Price by End User (2021-2026)

7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)

7.5.1 Global Lung Cancer Screening Historical Sales Volume, Revenue and Growth Rate of Hospitals (2021-2026)
7.5.2 Global Lung Cancer Screening Historical Sales Volume, Revenue and Growth Rate of Diagnostic Centers (2021-2026)
7.5.3 Global Lung Cancer Screening Historical Sales Volume, Revenue and Growth Rate of Others (2021-2026)


8 Leading Companies Profiles

8.1 Canon Medical Systems
8.1.1 Canon Medical Systems Corporation Information
8.1.2 Canon Medical Systems - Lung Cancer Screening Product Portfolio and Specification
8.1.3 Canon Medical Systems Performance Analysis (2021-2026)
8.1.4 Canon Medical Systems Business and Markets Served
8.1.5 Canon Medical Systems Recent Developments
8.2 General Electric
8.2.1 General Electric Corporation Information
8.2.2 General Electric - Lung Cancer Screening Product Portfolio and Specification
8.2.3 General Electric Performance Analysis (2021-2026)
8.2.4 General Electric Business and Markets Served
8.2.5 General Electric Recent Developments
8.3 Volpara Solutions Limited.
8.3.1 Volpara Solutions Limited. Corporation Information
8.3.2 Volpara Solutions Limited. - Lung Cancer Screening Product Portfolio and Specification
8.3.3 Volpara Solutions Limited. Performance Analysis (2021-2026)
8.3.4 Volpara Solutions Limited. Business and Markets Served
8.3.5 Volpara Solutions Limited. Recent Developments
8.4 Medtronic Plc
8.4.1 Medtronic Plc Corporation Information
8.4.2 Medtronic Plc - Lung Cancer Screening Product Portfolio and Specification
8.4.3 Medtronic Plc Performance Analysis (2021-2026)
8.4.4 Medtronic Plc Business and Markets Served
8.4.5 Medtronic Plc Recent Developments
8.5 Microsoft Corporation (Nuance Communications, Inc)
8.5.1 Microsoft Corporation (Nuance Communications, Inc) Corporation Information
8.5.2 Microsoft Corporation (Nuance Communications, Inc) - Lung Cancer Screening Product Portfolio and Specification
8.5.3 Microsoft Corporation (Nuance Communications, Inc) Performance Analysis (2021-2026)
8.5.4 Microsoft Corporation (Nuance Communications, Inc) Business and Markets Served
8.5.5 Microsoft Corporation (Nuance Communications, Inc) Recent Developments
8.6 Miltenyi Biotec
8.6.1 Miltenyi Biotec Corporation Information
8.6.2 Miltenyi Biotec - Lung Cancer Screening Product Portfolio and Specification
8.6.3 Miltenyi Biotec Performance Analysis (2021-2026)
8.6.4 Miltenyi Biotec Business and Markets Served
8.6.5 Miltenyi Biotec Recent Developments
8.7 Fujifilm Holdings Corporation
8.7.1 Fujifilm Holdings Corporation Corporation Information
8.7.2 Fujifilm Holdings Corporation - Lung Cancer Screening Product Portfolio and Specification
8.7.3 Fujifilm Holdings Corporation Performance Analysis (2021-2026)
8.7.4 Fujifilm Holdings Corporation Business and Markets Served
8.7.5 Fujifilm Holdings Corporation Recent Developments
8.8 Koninklijke Philips N.V.
8.8.1 Koninklijke Philips N.V. Corporation Information
8.8.2 Koninklijke Philips N.V. - Lung Cancer Screening Product Portfolio and Specification
8.8.3 Koninklijke Philips N.V. Performance Analysis (2021-2026)
8.8.4 Koninklijke Philips N.V. Business and Markets Served
8.8.5 Koninklijke Philips N.V. Recent Developments
8.9 Eon Health
8.9.1 Eon Health Corporation Information
8.9.2 Eon Health - Lung Cancer Screening Product Portfolio and Specification
8.9.3 Eon Health Performance Analysis (2021-2026)
8.9.4 Eon Health Business and Markets Served
8.9.5 Eon Health Recent Developments
8.10 Penrad Technologies Inc.
8.10.1 Penrad Technologies Inc. Corporation Information
8.10.2 Penrad Technologies Inc. - Lung Cancer Screening Product Portfolio and Specification
8.10.3 Penrad Technologies Inc. Performance Analysis (2021-2026)
8.10.4 Penrad Technologies Inc. Business and Markets Served
8.10.5 Penrad Technologies Inc. Recent Developments


9 Global Lung Cancer Screening Market Forecast by Product Type and End User (2026-2034)

9.1 Global Lung Cancer Screening Market Forecast by Product Type (2026-2034)

9.1.1 Global Lung Cancer Screening Sales Volume, Revenue Forecast and Growth Rate of Low Dose Computed Tomography (LDCT) (2026-2034)
9.1.2 Global Lung Cancer Screening Sales Volume, Revenue Forecast and Growth Rate of X-ray (2026-2034)
9.2 Global Lung Cancer Screening Market Forecast by End User (2026-2034)

9.2.1 Global Lung Cancer Screening Sales Volume, Revenue Forecast and Growth Rate of Hospitals (2026-2034)
9.2.2 Global Lung Cancer Screening Sales Volume, Revenue Forecast and Growth Rate of Diagnostic Centers (2026-2034)
9.2.3 Global Lung Cancer Screening Sales Volume, Revenue Forecast and Growth Rate of Others (2026-2034)


10 Global Lung Cancer Screening Market Forecast by Geographic Region (2026-2034)

10.1 Global Lung Cancer Screening Sales Volume and Revenue Forecast by Geographic Region (2026-2034)

10.2 North America Lung Cancer Screening Sales Volume, Revenue Forecast and Growth (2026-2034)

10.2.1 United States Lung Cancer Screening Sales Volume, Revenue Forecast and Growth (2026-2034)

10.2.2 Canada Lung Cancer Screening Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3 Europe Lung Cancer Screening Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.1 Germany Lung Cancer Screening Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.2 France Lung Cancer Screening Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.3 United Kingdom Lung Cancer Screening Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.4 Spain Lung Cancer Screening Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.5 Russia Lung Cancer Screening Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.6 Poland Lung Cancer Screening Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4 Asia Pacific Lung Cancer Screening Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.1 China Lung Cancer Screening Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.2 Japan Lung Cancer Screening Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.3 South Korea Lung Cancer Screening Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.4 Southeast Asia Lung Cancer Screening Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.5 India Lung Cancer Screening Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.6 Australia Lung Cancer Screening Sales Volume, Revenue Forecast and Growth (2026-2034)

10.5 Latin America Lung Cancer Screening Sales Volume, Revenue Forecast and Growth (2026-2034)

10.5.1 Mexico Lung Cancer Screening Sales Volume, Revenue Forecast and Growth (2026-2034)

10.5.2 Brazil Lung Cancer Screening Sales Volume, Revenue Forecast and Growth (2026-2034)

10.6 Middle East and Africa Lung Cancer Screening Sales Volume, Revenue Forecast and Growth (2026-2034)

10.6.1 GCC Lung Cancer Screening Sales Volume, Revenue Forecast and Growth (2026-2034)

10.6.2 South Africa Lung Cancer Screening Sales Volume, Revenue Forecast and Growth (2026-2034)



11 Appendix

11.1 Methodology

11.2 Research Data Source

11.2.1 Secondary Data

11.2.2 Primary Data

11.2.3 Market Size Estimation

11.2.4 Legal Disclaimer